Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

12

Revenue 2017

Bayer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bayer's 2013 sales performance.

Bayer

Roche’s Tecentriq/Avastin combo improves survival in liver cancer

Roche’s Tecentriq/Avastin combo improves survival in liver cancer death by 42% compared to Bayer’s Nexavar (sorafenib) when given as a first-line therapy for hepatocellular carcinoma (HCC) patients ineligible for surgery. ... able to achieve a significant improvement over Bayer’s drug on overall survival.

Sanofi said to be looking at options for $30bn consumer health unit

Sanofi said to be looking at options for $30bn consumer health unit Many have decided either to sell off the divisions in whole or in part – including Novartis, Merck KGaA, Bristol-Myers Squibb and Bayer for example – while GlaxoSmithKline and Pfizer both slimmed

Bayer, Merck’s high-risk heart failure drug comes good in phase 3

Bayer, Merck’s high-risk heart failure drug comes good in phase 3 Significantly reduced the risk of hospitalisation or cardiovascular death. Bayer and Merck &Co/MSD raised some eyebrows three years ago when they started a phase 3 programme for chronic heart failure ... The top-line readout suggests Merck and Bayer’s

BMS scores FDA priority review for Opdivo/Yervoy combo in liver cancer

BMS scores FDA priority review for Opdivo/Yervoy combo in liver cancer Bayer’s Nexavar (sorafenib).

Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture

Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture Under the deal, Biogen is taking exclusive rights to Samsung Bioepis’ SB11, a biosimilar of Novartis/Roche’s Lucentis (ranibizumab), as well as SB15 which is a version of ... It has since been overtaken by rival VEGF drug Eylea, with Regeneron

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics